or Try an Advanced Search...

    Technical Analysis for IVA - Inventiva S.A.

    Grade Last Price % Change Price Change
    C 2.63 -4.02% -0.11
    IVA closed unchanged on Wednesday, November 20, 2024, on 2 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical IVA trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish -4.02%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.02%
    Bollinger Band Squeeze Range Contraction -4.02%
    Gapped Down Weakness -4.02%
    20 DMA Support Bullish -4.02%
    Bollinger Band Squeeze Range Contraction -4.02%
    Outside Day Range Expansion -4.02%
    Up 3 Days in a Row Strength -4.02%
    Gapped Down Weakness -4.02%
    20 DMA Support Bullish -3.67%
    Older End-of-Day Signals for IVA ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 1 hour ago
    Gapped Down (Full) about 3 hours ago
    60 Minute Opening Range Breakout about 3 hours ago
    Lower Bollinger Band Support about 3 hours ago
    Gap Down Partially Closed about 3 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    IVA Chart by TradingView
    Basic chart:

    Profile

    Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Alcohol Genetics Hepatitis Steatohepatitis Gene Expression Non Alcoholic Fatty Liver Disease Fibrosis Small Molecule Therapies DNA Transcription Transcription Factors Epigenetics Transcription Factor Hepatitis A

    Is IVA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024
    Nov 20 Combined General Meeting of December 11, 2024 - Availability of the preparatory documents
    Nov 18 The first MASH drug could open the door for others — including GLP-1s
    Nov 15 Inventiva will present data from the final analysis of the Phase 2 study evaluating the combination of lanifibranor with empagliflozin in patients with MASH and T2D at the AASLD The Liver Meeting® late-breaker session
    Oct 30 Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH
    Oct 21 Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024
    Oct 15 Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data
    Oct 14 Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants
    Oct 14 Inventiva secures up to $380m for MASH treatment lanifibranor
    Oct 14 Why Is Fatty-Liver Drug Developer Inventiva Stock Trading Higher On Monday?
    See more IVA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.75
    52 Week Low 1.53
    Average Volume 267,240
    200-Day Moving Average 2.94
    50-Day Moving Average 2.36
    20-Day Moving Average 2.70
    10-Day Moving Average 2.70
    Average True Range 0.15
    RSI (14) 59.02
    ADX 17.72
    +DI 20.96
    -DI 16.56
    Chandelier Exit (Long, 3 ATRs) 2.40
    Chandelier Exit (Short, 3 ATRs) 2.93
    Upper Bollinger Bands 2.82
    Lower Bollinger Band 2.57
    Percent B (%b) 0.68
    BandWidth 9.37
    MACD Line 0.09
    MACD Signal Line 0.11
    MACD Histogram -0.0181
    Fundamentals Value
    Market Cap 141.51 Million
    Num Shares 51.6 Million
    EPS -2.05
    Price-to-Earnings (P/E) Ratio -1.34
    Price-to-Sales 8.77
    Price-to-Book 2.64
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.91
    Resistance 3 (R3) 2.89 2.81 2.88
    Resistance 2 (R2) 2.81 2.77 2.82 2.87
    Resistance 1 (R1) 2.78 2.75 2.80 2.80 2.86
    Pivot Point 2.70 2.70 2.71 2.71 2.70
    Support 1 (S1) 2.67 2.66 2.69 2.69 2.62
    Support 2 (S2) 2.59 2.64 2.60 2.61
    Support 3 (S3) 2.56 2.59 2.60
    Support 4 (S4) 2.58